Breaking News

RCUK Selects IDT as Preferred Oligo Supplier

Integrated DNA Technologies (IDT) has signed a three-year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides.

Integrated DNA Technologies (IDT) has signed a three-year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils. IDT will help RCUK in delivering on the UK government’s objectives for science and innovation.

“We are delighted to name IDT as one of our preferred suppliers of custom oligonucleotides,” said Richard Fowles, category manager, RCUK. He continued, “IDT’s advanced manufacturing capabilities will provide the scientists we fund with a broad range of synthetic oligos to cover all of their requirements.”

“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s 20-year commitment to innovation and quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” said Dr. Joseph A. Walder, IDT’s founder and chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters